Eslicarbazepine
Home / API - Commercial / Eslicarbazepine
CAS No.
236395-14-5
Therapeutic Category
- Anti-convulsant
Innovator Brand
ZEBINIX
GMP
Available
DMF
Not Available
Filed
Under Filing
Sample
Available
Indication
Aptiom is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.